Cullinan Oncology, Inc. (CGEM) Tops Q3 EPS by 18c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q3 EPS of ($0.77), $0.18 better than the analyst estimate of ($0.95).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Morgan Stanley upgrades Robinhood, sees 43% upside
• BMO Capital: 'Eli Lilly (LLY) to Acquire Precision I&I Biotech Merida Bio'